Information for Peptide: ENSLLFDPLSSSSSNK from AMPN_HUMAN
1. Biological Peptide
1.1 Native Sequence
R.ENSLLFDPLSSSSSNK.E
1.2 Peptide Properties
| Start | Stop | MW | m/z for 2+ | m/z for 3+ | pI |
|---|---|---|---|---|---|
| 364 | 379 | 1723.83 | 862.92 | 575.62 | 4.37 |
1.3 Fragment Ion Table
| AA | b Ion Series | b Ion Mass | y Ion Series | y Ion Mass |
|---|---|---|---|---|
| E | b | y | ||
| N | b | y | ||
| S | b | y | ||
| L | b | y | ||
| L | b | y | ||
| F | b | y | ||
| D | b | y | ||
| P | b | y | ||
| L | b | y | ||
| S | b | y | ||
| S | b | y | ||
| S | b | y | ||
| S | b | y | ||
| S | b | y | ||
| N | b | y | ||
| K | b | y |
2. Synthetic Peptide
2.1 Synthetic (Internal Standard) Peptide Sequence
(NONE)
2.2 Peptide Properties
(NONE)
2.3 Fragment Ion Table
(NONE)
2.4 Peptide Synthesis Report
(NONE)
2.5 QqQ MS/MS
2.6 Calibration Curve of Standard
Description: NONE
Experiment Description: Control urine was processed via ultrafiltration according to Moffitt Proteomics protocol and subjected to in-solution digestion with trypsin, following thermal denaturation, reduction, and alkylation.
2.7 LC-MRM Analysis of Biological and Standard Peptides Illustrates Elution Times
2.8 Pseudo MS/MS Comparison of Transition Patterns for Biological/Standard Peptides
